Hydromorphone Hydrochloride Tablet
NDC Package 42858-302-01
Package Information
Hydromorphone Hydrochloride tablets is hydromorphone Hydrochloride Oral Solution, USP and Hydromorphone Hydrochloride Tablets, USP are indicated for the management of pain in patients where an opioid analgesic is appropriate. This formulation utilizes a tablet delivery system. Marketed by Rhodes Pharmaceuticals Llc, this product is identified by NDC 42858-302 and is authorized under FDA application NDA019892.
Identification & Billing
- RxCUI: 897657 - HYDROmorphone HCl 1 MG in 1 mL Oral Solution
- RxCUI: 897657 - hydromorphone hydrochloride 1 MG/ML Oral Solution
- RxCUI: 897657 - hydromorphone HCl 1 MG per 1 ML Oral Solution
- RxCUI: 897657 - hydromorphone HCl 5 MG per 5 ML Oral Solution
- RxCUI: 897696 - HYDROmorphone HCl 2 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 42858 - Rhodes Pharmaceuticals Llc
- 42858-302 - Hydromorphone Hydrochloride
- 42858-302-01 - 100 TABLET in 1 BOTTLE, PLASTIC
- 42858-302 - Hydromorphone Hydrochloride
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (42858-302). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 42858-302-01 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Hydromorphone Hydrochloride, a human prescription drug labeled by Rhodes Pharmaceuticals Llc. This tablet is formulated for oral use and contains hydromorphone hydrochloride as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rhodes Pharmaceuticals Llc on November 23, 2009. The current certification is valid through December 31, 2027.
How is this Rhodes Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 42858030201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.